Loading clinical trials...
Loading clinical trials...
Investigating the Impact of Oxytocin on Irritability/Emotional Dysregulation in Children and Adolescents With Disruptive Behavior and Mood Disorders, and the Possible Mediating Role of Amygdala Activity
Conditions
Interventions
Oxytocin
Placebo
Locations
1
United States
University of Nebraska Medical Center, Department of Psychiatry
Omaha, Nebraska, United States
Start Date
January 27, 2017
Primary Completion Date
August 10, 2021
Completion Date
August 10, 2021
Last Updated
October 5, 2023
NCT06984809
NCT06831435
NCT06481033
NCT07088939
NCT06275217
NCT05832489
Lead Sponsor
University of Nebraska
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions